Introduction Abbott has four reportable segments: Established Pharmaceuticals, Diagnostics, Nutritional Products, and Medical Devices. Asset Structure Analysis Abbott’s total assets were $73.2 billion as of December 31, 2023, down from $74.4 billion as of December 31, 2022. Abbott’s asset structure as of December 31, 2023 Deferred income saxes and other assets were $7.1 billion, accounting…